Myriad Genetics: In the eye of the policy storm
Authors:
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 12 (4) , S39-S70
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Author Index Volume 130 (2008)Journal of Controlled Release, 2008
- Navigating the molecular diagnostic patent landscapeExpert Opinion on Therapeutic Patents, 2008
- When research seems like clinical care: a qualitative study of the communication of individual cancer genetic research resultsBMC Medical Ethics, 2008
- Evidence and anecdotes: an analysis of human gene patenting controversiesNature Biotechnology, 2006
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer SusceptibilityJournal of Clinical Oncology, 2003
- Interest in BRCA1/2 Testing in a Primary Care PopulationPreventive Medicine, 2002
- The European Biotech Directive: Past as PrologueEuropean Law Journal, 2001
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990